Hämostatische Funktionen der Endothelzelle

• LITERATUR

• 1 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-56.
• 2 Delvos U, Müller-Berghaus G. Die Regulation der Blutgerinnung. Naturwissenschaften 1985; 72: 461-469.
• 3 Müller-Berghaus G. Physiologie der Blutgerinnung und Fibrinolyse. In: Transfusionsmedizin. Mueller-Eckhardt C. (ed) Berlin: Springer; 1988: 53-78.
• 4 Siedlecki CA, Lestini BJ, Kottke-Marchant K. et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996; 88: 2939-50.
• 5 Gimbrone Jr MA. (ed) Vascular Endothelium in Hemostasis and Thrombosis. Edinburgh: Churchill Livingstone; 1986
• 6 Brenner BM, Troy JL, Ballermann BJ. Endothelium-dependent vascular responses. Mediators and mechanisms. J Clin Invest 1989; 84: 1373-8.
• 7 Lilly LS, Pratt RE, Alexander RW. Renin expression by vascular endothelial cells in culture. Circ Res 1985; 57: 312.
• 8 Johnson AR, Erdos EG. Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin 1 converting enzyme (kininase II) and angiotensinase. J Clin Invest 1977; 59: 684.
• 9 Palmieri FE, Bausback HH, Churchill L. Kinin and enkephalin conversion by an endothelial plasma membrane carboxypepti-dase. Biochem Pharmacol 1986; 35: 2749-56.
• 10 Del Vecchio PJ, Ryan JW, Chung A. Capillaries of the adrenal cortex possess amino-peptidase A and angiotensin converting enzyme activities. Biochem J 1980; 186: 605-8.
• 11 Palmieri FE, Bausback HH, Ward PE. Metabolism of vasoactive peptides by vascular endothelium and smooth muscle amino-peptidase M. Biochem Pharmacol 1989; 38: 173-80.
• 12 Yanagisawa M, Kurihara H, Kimura S. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-5.
• 13 Moneada S, Palmer RMJ, Higgs EA. Prostacyclin and endothelium-derived relaxing factor: Biological interactions and significance. In: Thrombosis and Haemostasis. Verstraete M, Vermylen J, Lijnen HR, Arnout J. (eds) Leuven: International Society on Thrombosis and Haemostasis and Leuven University Press; 1987: 597-618.
• 14 Busse R, Trogisch G, Bassenge E. The role of endothelium in the control of vascular tone. Basic Res Cardiol 1985; 80: 475-90.
• 15 Shepro D, Dunham B. Endothelial cell metabolism of biogenic amines. Ann Rev Physiol 1986; 48: 335-45.
• 16 Smith JA, Henderson AH, Randall MD. Endothelium-derived relaxing factor, prostanoids and endothelins. In: Haemostasis and Thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. (eds) Edinburgh: Churchill Livingstone; 1994: 183-97.
• 17 Sixma JJ. Interaction of blood platelets with the vessel wall. In: Haemostasis and Thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. (eds) Edinburgh: Churchill Livingstone; 1994: 259-85.
• 18 Nievelstein PFEM, de Groot PG. Interaction of blood platelets with the vessel wall. Haemostasis 1988; 18: 342-59.
• 19 Vanhoutte PM. Platelets, endothelium and blood vessel wall. Experientia 1988; 44: 105-9.
• 20 Marcus AJ. Multicellular eicosanoid and other metabolic interactions of platelets and other cells. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds) Philadelphia: J. B. Lippincott; 1994: 590-602.
• 21 Jaffe EA, Hoyer LW, Nachman RL. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 1974; 71: 1906-9.
• 22 Prescott SM, Mclntyre TM, Zimmerman GA. The role of platelet-activating factor in endothelial cells. Thromb Haemost 1990; 64: 99-103.
• 23 Zimmerman GA, Mclntyre TM, Mehra M. Endothelial cell-associated platelet-activating factor: a novel mechanism for signaling intercellular adhesion. J Cell Biol 1990; 110: 529.
• 24 Radomski MW, Palmer RM, Moneada S. The anti-aggregating and nitric oxide. Br J Pharmacol 1987; 92: 639-46.
• 25 Rees DD, Palmer RMJ, Moneada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci 1989; 86: 3375.
• 26 Gordon JL, Pearson JD. Biology of the vascular endothelium. In: Haemostasis and Thrombosis. Bloom AL, Thomas DP. (eds) Edinburgh: Churchill Livingstone; 1987: 303-11.
• 27 Shepro D, Dunham B. Physiology of the vessel wall. In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds) Philadelphia: J. B. Lippincott; 1987: 781-92.
• 28 Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cell. J Immunol 1986; 137: 1532-7.
• 29 Carlsen E, Flatmark A, Prydz H. Cytokine-induced procoagulant activity in monocytes and endothelial cells: further enhancement by cyclosporine. Transplantation 1988; 46: 575.
• 30 Stern DM, Kaiser E, Nawroth PP. Regulation of the coagulation system by vascular endothelial cells. Haemostasis 1988; 18: 202-14.
• 31 Cerveny TJ, Fass DN, Mann KG. Synthesis of coagulation factor V by cultured aortic endothelium. Blood 1984; 63: 1467-74.
• 32 Maruyama I, Salem HH, Majerus PW. Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation. J Clin Invest 1984; 74: 224-30.
• 33 Stern DM, Drillings M, Nossel HL. et al. Binding of factors IX and IXa to cultured vascular endothelial cells. Proc Natl Acad Sci USA 1983; 80: 4119-23.
• 34 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743.
• 35 Dahlbäck B, Stenflo J. A natural anticoagulant pathway: proteins C, S, C4b-binding protein and thrombomodulin. In: Haemostasis and Thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. (eds) Edinburgh: Churchill Livingstone; 1994: 671-98.
• 36 Fair DS, Mailar RA, Levin EG. Human endothelial cells synthesize protein S. Blood 1986; 67: 1168-71.
• 37 Walker FJ. Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 1980; 255: 5521-4.
• 38 Preissner KT. Heparinoids and cellular interactions in the vascular system. Hae-mostas 1996; 14: 496-502.
• 39 Dawes J, Pepper DS. Human vascular endothelial cells catabolise exogenous glycosami-noglycans by a novel route. Thromb Haemost 1992; 67: 468-72.
• 40 Oldberg A, Heldin C-H, Wasteson A. Characterization of a platelet endoglycosi-dase degrading heparin-like polysaccharides. Biochemistry 1980; 19: 5755-62.
• 41 Busch C, Owen WG. Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium. J Clin Invest 1982; 69: 726-9.
• 42 Briginshaw GF, Shanberge JN. Identification of two distinct heparin cofactors in human plasma. Separation and partial purification. Thromb Res 1974; 4: 683-90.
• 43 Tollefsen DM, Blank MK. Detection of a new heparin-dependent inhibitor of thrombin in human plasma. J Clin Invest 1981; 68: 589-96.
• 44 Tollefsen DM, Pestka CA, Monafo WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983; 258: 6713-6.
• 45 Broze Jr GJ, Miletich JP. Characterization of the inhibition of tissue factor in serum. Blood 1987; 69: 150-5.
• 46 Broze Jr GJ. The tissue factor pathway of coagulation: factor VII, tissue factor, and tissue factor pathway inhibitor. In: Haemo stasis and Thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. (eds) Edinburgh: Churchill Livingstone; 1994: 349-77.
• 47 Lindahl AK, Sandset PM, Abildgaard U. The present status of tissue factor pathway inhibitor. Blood Coagul Fibrinol 1992; 3: 439-49.
• 48 Reutelingsperger CPM, Hornstra G, Hemker HC. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985; 151: 625-9.
• 49 Römisch J, Schorlemmer U, Fickenscher K. et al. Anticoagulant properties of placenta protein 4 (annexin V). Thromb Res 1990; 60: 355-66.
• 50 Leroy-Viard K, Jandrot-Perrus M, Tobelem G. Covalent binding of human thrombin to a human endothelial cell-associated protein. Exp Cell Res 1989; 181: 1-10.
• 51 Hiramoto SA, Cunningham DD. Effects of fibroblasts and endothelial cells on inactiva-tion of target proteases by protease nexin-1, heparin cof actor II, and CI-inhibitor. J Cell Biochem 1988; 36: 199.
• 52 van Hinsbergh VWM. Regulation of the synthesis and secretion of plasminogen activators by endothelial cells. Haemostasis 1988; 18: 307-27.
• 53 Hajjar KA, Nachman RL. The human endothelial cell plasmin-generating system. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzrnan EW. (eds) Philadelphia: J. B. Lippincott; 1994: 823-36.
• 54 Hajjar KA, Harpel PC, Jaffe EA, Nachman RL. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 1986; 261: 11656-62.
• 55 Schleef RR, Loskutoff DJ. Fibrinolytic system of vascular endothelial cells. Role of plasminogen activator inhibitors. Haemostasis 1988; 18: 328-41.
• 56 Lecander I, Astedt B. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol 1986; 62: 221-8.
• 57 Mimuro J, Loskutoff DJ. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells. J Biol Chem 1989; 264: 5058-63.
• 58 Schleef RR, Podor TJ, Dunne E. et al. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator. J Cell Biol 1990; 110: 155-63.
• 59 Preissner KT, de Boer H, Pannekoek H, de Groot PG. Thrombin regulation by physiological inhibitors: The role of vitronectin. Sem Thromb Hemostas 1996; 22: 165-72.
• 60 Declerck PJ, De Mol M, Alessi M-C. et al. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 1988; 263: 15454-61.
• 61 Sakata Y, Loskutoff DJ, Gladson CL. et al. Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor. Blood 1986; 68: 1218-23.
• 62 Weimar B, Delvos U. The mechanism of fibrin-induced disorganization of cultured human endothelial cell monolayers. Arteriosclerosis 1986; 6: 139-45.
• 63 Speiser W, Anders E, Preissner KT. et al. Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue micro-vessels and umbilical veins. Blood 1987; 69: 964-7.
• 64 Levin EG, Marzek U, Anderson J, Harker LA. Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest 1984; 74: 1988-995.
• 65 Wojta J, Jones RL, Binder BR. Reduction in P0₂ decreases the fibrinolytic potential of cultured bovine endothelial cells derived from pulmonary arteries and lung microvas-culature. Blood 1988; 71: 1703.
• 66 Speiser W. Das antithrombotische Potential des Gefäßendothels. Hämostaseologie 1987; 7: 63-72.
• 67 Levin EG, Loskutoff DJ. Comparative studies in the fibrinolytic activity of cultured vascular cells. Thromb Res 1979; 15: 869-78.
• 68 Cheng YF, Kramer RH. Human microvascular endothelial cells express integrin-related complexes that mediate adhesion to the extracellular matrix. J Cell Physiol 1989; 139: 275-86.
• 69 Dejana E, Needham L, Gordon J. Endothelial cell adhesive interactions. Mechanisms and consequences. In: Endothelial Cell Dysfunctions. Simionescu N, Simionescu M. (eds) New York: Plenum; 1992: 153-68.
• 70 Giltay JC, van Mourik JA. Structure and function of endothelial cell integrins. Haemostasis 1988; 18: 376-89.
• 71 Reinders JH, de Groot PG, Sixma JJ, van Mourik JA. Storage and secretion of von Willebrand factor by endothelial cells. Haemost 1988; 18: 246-61.
• 72 Ugarova T, Agbanyo FR, Plow EF. Conformational changes in adhesive proteins modulate their adhesive function. Thromb Haemost 1995; 74: 253-7.
• 73 Hawiger J. Adhesive interactions of blood cells and the vascular wall. In: Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Colman RW, Hirsh J, Marder VJ, Salzrnan EW. (eds) Philadelphia: J. B. Lippincott; 1994: 762-96.
• 74 Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491-7.
• 75 de Boer HC, Preissner KT, Bouma BN, de Groot PG. Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. J Biol Chem 1992; 267: 2264-8.
• 76 Preissner KT, Kanse S. Protease-receptors in the vasculature: Novel aspects of regulation of hemostasis and wound repair. Biomed Progr 1996; 9: 22-7.
• 77 Müller-Berghaus G. Physiologie des Hämostasesystems. In: Transfusionsmedizin. Mueller-Eckhardt C. (Hrsg) Heidelberg: Springer; 1996: 47-75.